)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Arterra Bioscience
Arterra Bioscience (ARBS) investor relations material
Arterra Bioscience H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary29 Sep, 2026
Executive summary
Revenue for H1 2026 reached €3.03M, up 18% year-over-year, driven by higher sales of cosmetic raw materials, research services, and capital contributions from funded projects.
Net profit for H1 2026 was €742K, compared to €319K in H1 2025, reflecting improved operating performance, though some sources report a decline from €1.09M in H1 2025.
The company distributed €977K in dividends from the previous year's profit.
Equity as of June 30, 2026, stood at €12.35M, slightly down due to dividend distribution and compared to €12.6M at year-end 2025.
The company remains optimistic about achieving full-year targets, with early H2 2026 sales continuing the positive trend.
Financial highlights
Total production value rose to €3.47M from €3.14M in H1 2025.
Operating costs increased to €2.46M, mainly due to higher personnel and service expenses.
EBITDA margin remained strong, with a difference between production value and costs of €1.02M.
Cash and cash equivalents at period end were €1.31M.
Total assets as of June 30, 2026: €14.6M.
Outlook and guidance
Strong order backlog and H1 growth, along with early H2 sales, support optimism for achieving 2026 growth targets.
Ongoing advanced research projects are expected to deliver innovative products to market in the near future.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Arterra Bioscience
- Green biotech innovator with key partnerships in cosmetics and agriculture.ARBS
Q2 2026 TU - Revenue up 43% in 1H 2024, led by strong cosmetic raw material sales growth.ARBSQ2 2024 TU
- Revenue up 7% year-over-year to €2.8 million, with strong growth in cosmetic raw materials.ARBSQ3 2024 TU
- Revenue up 28.21% to €4.2M, driven by strong cosmetic raw materials sales growth.ARBSQ4 2024 TU
- Q1 2025 revenue rose 21.6% year-over-year to €1.3 million, led by cosmetic raw material sales.ARBSQ1 2025 TU
- Revenue up 12.8% year-over-year to €2.6M, led by strong cosmetic raw material sales growth.ARBSQ2 2025 TU
- Revenue up 29% year-over-year to €3.6M, with strong growth in cosmetic raw materials sales.ARBSQ3 2025 TU
- Net profit more than doubled to €1.09M as production value and EBITDA surged.ARBSH1 2025
- Net profit more than doubled on 41% revenue growth, driven by strong cosmetic raw material sales.ARBSH1 2024
Next Arterra Bioscience earnings date
H2 20269 Apr, 2027
Arterra Bioscience
Next Arterra Bioscience earnings date
H2 20269 Apr, 2027
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage